Medicine and Pharmaceuticals are forever changing. Whether new treatments or drugs come to light or existing ones are tested to see whether they can be used to help other conditions. Clinical trials are established to look at home the drugs or treatments perform and the ways in which they affect the patients who take part in the study both in a positive and negative way.
All drugs and treatments have to go through this process before they can be cleared for use by the medical community across the general population. There are ways in which studies can be sped up and how they can cover a number of different countries.
As each country is governed by a different medical authority that oversees the studies it can be difficult to work on a study that will be cleared across more than one area. This is where Bridging Studies can help. This can include everything from Adaptive Phase 1 Clinical Studies like the ones from https://www.richmondpharmacology.com/specialist-services/adaptive-phase-i-studies as well as traditional clinical trials. These studies allow for the clinical trials to take place and the data to be extrapolated and used across a number of different countries. Each country may require the data reported to be tested in a number of different ways but it allows for more timely research to be undertaken and for countries to quickly and easily share their findings.